<DOC>
	<DOCNO>NCT00011076</DOCNO>
	<brief_summary>This study examine effectiveness drug pirfenidone ( Deskar ) improve heart function patient hypertrophic cardiomyopathy ( HCM ) . Stiffening heart muscle patient HCM impair heart 's ability relax thus fill empty properly . This lead heart failure , breathlessness excessive fatigue . The heart 's inability relax may due scar , fibrosis , muscle wall . This study test whether pirfenidone reduce fibrosis , improve heart relaxation reduce abnormal heart rhythm . Men woman 20 75 year old HCM may eligible study . Participants undergo physical examination , blood test , test procedure , describe , assess heart function . When test complete , patient randomly assign one two treatment group . One group take pirfenidone capsule take placebo ( look-alike pill active ingredient ) twice day meal 6 month . For pirfenidone group , dose drug increase gradually 400 800 milligram . At end 6 month , patient repeat physical examination heart test do start medication . These include : - Electrocardiogram ( ECG ) - electrode attached heart record heart 's electrical activity , provide information heartbeat . - Echocardiogram - probe hold chest wall use sound wave produce image heart , provide information function heart chamber . - 24-hour Holter monitor - 24-hour record electrical activity heart monitor abnormal heartbeat conduction abnormality . - Magnetic resonance imaging ( MRI ) - Radiowaves strong magnetic field use produce image heart , provide information thickness movement heart muscle . - Radionuclide angiogram - radioactive tracer inject vein special camera use scan heart , provide information beat motion heart . Scans obtain rest exercise . - Cardiac ( heart ) catheterization - catheter ( thin plastic tube ) insert blood vessel groin advance heart record pressure take picture inside heart . - Electrophysiology study - catheter insert blood vessel groin advance heart record electrical activity , provide information abnormal heart rhythm . This procedure do time heart catheterization . - Cardiac biopsy - catheter insert blood vessel groin advance heart remove small sample heart muscle microscopic examination . This procedure do end heart catheterization .</brief_summary>
	<brief_title>Pirfenidone Treat Hypertrophic Cardiomyopathy</brief_title>
	<detailed_description>Left ventricular ( LV ) diastolic dysfunction arrhythmia important cause morbidity mortality HCM . These abnormality believe part due myocardial fibrosis frequently complicate HCM . Several study indicate pirfenidine safely inhibit progression cause regression fibrotic lesion . We therefore propose perform six-month study examines ability pirfenidone improve LV diastolic dysfunction , exercise performance , electrophysiologic abnormality symptomatic patient severe HCM .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<mesh_term>Pirfenidone</mesh_term>
	<criteria>INCLUSION CRITERIA : Male female patient age 20 75 year . Cardiac symptom : New York Heart Association Functional Class IIIV despite medical therapy . Maximum LV wall thickness great 15 mm assess echo MRI . Mean pulmonary capillary wedge pressure great equal 18 mm Hg and/or LV enddiastolic pressure great equal 18 mm Hg . EXCLUSION CRITERIA : LV outflow tract gradient great 40 mm Hg cardiac catheterization . Coronary artery disease ( great 50 % arterial luminal narrowing major epicardial vessel ) . Chronic atrial flutter/fibrillation Pregnancy breastfeeding . Treatment immunosuppressant medication last 90 day . Active neoplastic disease . Significant renal ( serum creatinine great 1.5 x upper reference limit ) hepatic ( transaminases great 2 x upper reference limit ) dysfunction . Use overthecounter medication , herbal therapy may cardioactive .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2003</verification_date>
	<keyword>Deskar</keyword>
	<keyword>Fibrosis</keyword>
	<keyword>Myocardium</keyword>
	<keyword>Scarring</keyword>
	<keyword>Arrhythmia</keyword>
	<keyword>Hypertrophic Cardiomyopathy</keyword>
	<keyword>Left Ventricular Diastolic Dysfunction</keyword>
	<keyword>Myocardial Fibrosis</keyword>
</DOC>